<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-pharmaceutics-11-00040" class="ref">
 <label class="label">41.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Elmataeeshy</surname>
    <given-names class="given-names">M.E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sokar</surname>
    <given-names class="given-names">M.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bahey-El-Din</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shaker</surname>
    <given-names class="given-names">D.S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Enhanced transdermal permeability of Terbinafine through novel nanoemulgel formulation; Development, in vitro and in vivo characterization</article-title>
  <source class="source">Future J. Pharm. Sci.</source>
  <year class="year">2018</year>
  <volume class="volume">4</volume>
  <fpage class="fpage">18</fpage>
  <lpage class="lpage">28</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.fjps.2017.07.003</pub-id>
 </element-citation>
</ref>
